This is a preview of subscription content, log in via an institution to check access.
Notes
2019 euros
Swedish krona
Reference
Mahon R, et al. Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden PharmacoEconomics : 25 Jan 2021. Available from: URL: https://doi.org/10.1007/s40273-020-00996-2
Rights and permissions
About this article
Cite this article
Erenumab cost effective for migraine prevention in Sweden. PharmacoEcon Outcomes News 871, 16 (2021). https://doi.org/10.1007/s40274-021-7454-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7454-0